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Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world.
Humanized disease models are required to develop new therapies for currently incurable forms of AMD.
In this work, a tissue-on-a-chip approach was developed through combining human induced plur-
ipotent stem cells, Electric Cell–substrate Impedance Sensing (ECIS) and reproducible electrical
wounding assays to model and quantitatively study AMD. Retinal Pigment Epithelium (RPE) cells gen-
erated from a patient with an inherited macular degeneration and from an unaffected sibling were used
to test the model platform on which a reproducible electrical wounding assay was conducted to model
RPE damage. First, a robust and reproducible real-time quantitative monitoring over a 25-day period
demonstrated the establishment and maturation of RPE layers on the microelectrode arrays. A spatially
controlled RPE layer damage that mimicked cell loss in AMD disease was then initiated. Post recovery,
signiﬁcant differences (Po0.01) in migration rates were found between case (8.670.46 μm/h) and
control cell lines (10.6970.21 μm/h). Quantitative data analysis suggested this was achieved due to
lower cell–substrate adhesion in the control cell line. The ECIS cell–substrate adhesion parameter (α) was
found to be 7.870.28Ω1/2 cm for the case cell line and 6.570.15Ω1/2 cm for the control. These ﬁndings
were conﬁrmed using cell adhesion biochemical assays. The developed disease model-on-a-chip is a
powerful platform for translational studies with considerable potential to investigate novel therapies by
enabling real-time, quantitative and reproducible patient-speciﬁc RPE cell repair studies.
& 2015 Published by Elsevier B.V.1. Introduction
Age-related Macular Degeneration (AMD) is the most common
cause of blindness in the developed world (Johnson et al., 2005).
The disease usually affects patients in their seventh and eighth
decades resulting in the loss of functionally important central vi-
sion. There are two main forms of the disease; wet AMD, in whichBagnaninchi).sub-retinal vascular leakage predominates and dry AMD in which
deposit formation and cell degeneration are the primary disease
processes. Although treatments have recently been developed for
wet AMD there is currently no effective treatment for dry AMD.
The Retinal Pigment Epithelium (RPE) is a pigmented, polygonal
monolayer of cells found directly below the photoreceptor layer in
the retina. The primary role of the RPE is in photoreceptor
homeostasis. RPE dysfunction, degeneration and reduced repair
are implicated in the AMD disease process (Cai and Del Priore,
2006; Thurman et al., 2009). In normal ageing, RPE cell loss is
compensated for by increasing cell size and migration of neigh-
boring RPE (Panda-Jonas and Jonas, 1996). In AMD however,
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coverage and the consequent death of overlying photoreceptors.
Late onset retinal macular degeneration (LORMD) is a rare, auto-
somal dominant form of macular degeneration (Hayward et al.,
2003). LORMD shares key clinical and pathological features with
AMD including dark adaptation delay, drusenoid retinal changes
prior to sub-retinal deposit, RPE cell loss and neuro-retinal atrophy
and has thus been proposed as a good model for AMD (Borooah
et al., 2009). In vitro RPE models are required to investigate the
underlying mechanisms associated with AMD. However, it is dif-
ﬁcult to obtain and culture primary functional human retinal cells,
hence the predominance of immortalized cell lines in AMD re-
search (Borooah et al., 2013). In most cases though, the behavior of
these immortalized lines poorly reﬂects what actually happens
in vivo (Alge et al., 2006; Klimanskaya et al., 2004. Human induced
Pluripotent Stem Cells (hiPSCs) technology offers a novel approach
for disease modeling, with the potential to impact translational
retinal research and therapy. Recent developments enable the
generation of RPE cells derived from patients (hiPSC-RPE) thus
allowing in vitro study of human retinal disease that has greater
clinical and physiological relevance (Meyer et al., 2009; Takahashi
et al., 2007). In this study, RPE was derived from both a patient
with an LORMD and from an unaffected sibling (Borooah et al.,
2009).
In addition to the limitations of in vitro RPE models, a number
of issues associated with the study of wound healing in biology
have hampered the development of relevant AMD models. Me-
chanical wounding methods including scratching (Li et al., 2009;
Fronzaa et al., 2009) and stamping are the most commonly used
wound healing assays (Lee et al., 2010). Scratching assays however
does not produce a highly repeatable wound; a disadvantage that
can be overcome by stamping. These methods can also disrupt the
ECM layer as well as form debris that might affect the migration
process. Gap closure assays can be used to produce cell free re-
gions where cell migration can be monitored after removing a
solid (Poujade et al., 2007), liquid (Doran et al., 2009) or gel barrier
(Varani et al., 1978). Cells grow around the physical barrier and
migrate upon removal. Other wounding techniques include che-
mical (Legrand et al., 1999) and optical methods (Zordan et al.,
2011). However, most of the above methods require extensive
manipulation of the cell layer during both wounding as well as
repair processes. Moreover, problems of quantiﬁcation and re-
producibility occur due to the difﬁculty of controlling the woun-
ded areas.
In order to overcome both cell source and current wounding
assays limitations, a tissue-on-a-chip approach was investigated
by developing and characterising a human induced pluripotent
stem cells model of RPE layer on Electric Cell–substrate Impedance
Sensing microelectrode arrays. Electric Cell–substrate Impedance
Sensing (ECIS) is a technology pioneered by Giaever and Keese in
which a small non-invasive AC current (1 μΑ) is applied using
gold microelectrodes (Giaever and Keese, 1984; Giaever and Keese,
1991). Changes in the time-course complex impedance associated
with cellular events are monitored by means of in-phase and out-
of-phase measurements using a lock-in-ampliﬁer (Giaever and
Keese, 1991). ECIS has found many applications from cell attach-
ment and spreading (Wegener et al., 2000; Lo et al., 1995), signal
transduction (Han et al., 2009), cytotoxicity (Opp et al., 2009;
Lovelady et al., 2009) to metastasis (Keese et al., 2002) and more
recently regenerative medicine (Bagnaninchi and Drummond,
2011). ECIS migration assays also allow the combination of elec-
trical wounding and impedance spectroscopy to quantitatively and
reproducibly measure cell migration rates and changes in cell
morphology accompanying wound healing (Wegener et al., 2000).
In this paper, the need for a physiologically relevant in vitro
model of RPE layer repair that can be investigated quantitativelyand reproducibly has been addressed through developing a tissue-
on-a-chip approach. First the hiPSC-RPE model was established
and characterised on ECIS microelectrode arrays. Then an electrical
wound healing assay was used to mimic RPE cell damage in both
control and diseased hiPSC-RPE cell lines to study differences in
repair. Finally the disease model-on-a-chip was used to answer a
series of questions concerning the role of RPE adhesion in repair
pointing towards potential therapeutic strategies.2. Materials and methods
2.1. Generation of hiPSC-RPE lines
Derivation of hiPSC lines from one patient with late-onset
retinal macular degeneration (LORMD) and one unaffected sibling
was achieved using previously established methods (Bilican et al.,
2012; Yusa et al., 2011). RPE differentiation was then established
using a variation of a previously published protocol (Meyer et al.,
2009). For more details on the protocols used, see Supplementary
data. The cells were maintained as adherent cultures in retinal
differentiation medium (RDM) until the appearance of pigmented
RPE cells. Large patches of pigmented RPE cells were micro-dis-
sected and then grown on laminin coated plates initially in 10%
FBS/RDM 90% for two days, followed by 2% FBS/98% RDM till
conﬂuent before switching to RDM. RPE validation was performed
using RT-PCR and immunostaining.
2.2. Quantitative real-time PCR (RT PCR)
Total RNA was extracted using the RNAeasy Mini Plus Kit
(Qiagen) and treated with DNase1 to remove any genomic DNA
contamination. Synthesization of cDNA was performed using a
cDNASynthesis Kit (Thermo Scientiﬁc), and PCR (34 cycles) was
performed using gene-speciﬁc primers. PCR products were ana-
lyzed on 2% agarose gels. Quantitative RT PCR experiments (40
cycles) were carried out using SYBRs Green Supermix (Bio-Rad)
and a Bio-Rad C1000 thermal cycler, and results were analyzed
using Bio-Rad CFX software and Microsoft Excel.
2.3. Tissue culture on microelectrode arrays
Case and Control hiPSC-RPE were cultured on ECIS medusa
arrays (Applied Biophysics, NY, USA) incorporating a 2-electrode
set up: working and counter electrodes. Each array has 8 wells of
0.8 cm2 surface area with two 250 μm diameter gold working
microelectrodes per well. Microelectrodes are fabricated on a
transparent Lexan polycarbonate substrate onto which 50 nm
thick gold electrodes are sputtered and passivated with 2 mm
polymer resin. Sensing electrodes have a typical area of 0.05 mm2
while the counter electrode has an area of 18 mm2. The spacing
between the electrodes on a medusa array is 4.83 mm. Because the
area of the counter electrode is much larger than that of the
working electrode, its impedance contribution can be neglected.
The two working electrodes are addressed individually and mea-
surements from one working electrode are recorded at a time. The
ECIS electrode array was placed in an array holder inside a hu-
midiﬁed incubator at 37 °C and 5% CO2. All wells were incubated
for 2 h with the culture medium before seeding at conﬂuency
(100,000 cells/well). Cells were initially cultured with retinal dif-
ferentiation mediumwith 10% fetal calf serum. On day 2 of culture,
the media was changed into RDM 2% serum and on day 6, RDM
with no serum was used until the end of the experiment. Media
was changed 3 times per week. Cells were cultured for 25 days to
achieve RPE maturation before starting the wound healing assay.
Immortalized RPE cell lines with hTERT (hTERT-RPE1, ATCC)
Fig. 1. Development and characterization of the hiPSC-RPE model on ECIS microelectrodes. (a) Patient's ﬁbroblasts were expanded and reprogrammed with Yamanaka factors Klf4,
Oct3/4, Sox2, c-Myc to a pluripotent state before being differentiated to RPE. Cells were plated (Day 0) on ECIS microarrays before being allowed to mature for an additional 3 weeks
period. (b) Timeline protocol: Cells were cultured with a density of 100,000 cells/cm2. Culturing mediumwas switched from RDM 10% FCS to RDM 2% FCS on Day 2 of culture, and then
to RDM no serum on Day 6. Mediumwas changed every other day for 25 days until RPE maturationwas obtained. (c) The complex impedance was monitored in real-time throughout
RPE maturation and is displayed as the resistance at 4 kHz. It showed an increase with cell spreading and maturation followed by a decrease reﬂecting changes in cell morphology and
size. After 25 days, an automated electrical wound healing assay was performed and subsequent cell migration associated with healing phase was monitored. (d) Immunostaining
showing the expression of the transmembrane RPE speciﬁc protein Bestrophin(red), Ezrin (green) and DAPI (blue) illustratedmarkers of mature RPE. (e) RT-PCR revealed that both case
and control hiPSC-RPE lines expressed global epithelial and RPE speciﬁc markers.
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Fig. 2. ECIS Wound Healing Assay of hiPSC-derived RPE. (a) Wounding hiPSC-RPE: The resistance kinetics for one case study after wounding and during healing was monitored. Cells
were wounded using wounding parameters of 3 mA, 40 kHz, 30 s. Trypan blue was used to stain dead cells that did not detach from the electrodes. (b) Wounding was a reproducible
process, producing a deﬁned wound every time. The control cell line migrated faster than the case cell line to achieve wound healing. (c) Sigmoid ﬁtting: the case and control healing
curves were ﬁtted to a sigmoid curve. The parameters of the ﬁtting curve were further analyzed. (d) Migration rate bar graphs: the control migration rate was 10.6970.21 μm/h while
that of the case cell line was 8.670.46 μm/h. The two rates were signiﬁcantly different (P¼0.0046). (e) Sigmoid hill slope: the difference between the control and case hill slopes were
not signiﬁcantly different. (f) Inﬂection points were found signiﬁcantly different.
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(FBS) and 0.01 mg/ml hygromycin B. Cells were seeded with a
density of 40,000 cells/well and cultured for two days before
starting the migration assay. Culturing medium was changed
3 times per week.
2.4. Impedance sensing
A commercial Electric Cell–Substrate Impedance Sensing in-
strument (ECIS Z⦵, Applied Biophysics) was used to record mul-
tiple frequency impedance measurements (62.5, 125, 250, 500,
1000, 2000, 4000, 8000, 16,000, 32,000 and 64,000 Hz) every
160 s. The measured complex impedance had a resistive and ca-
pacitive component which was determined through in-phase and
out-of-phase measurements using a lock-in ampliﬁer.
In this study spectroscopic impedance data were presented
only at low (4 kHz) and high frequency (64 kHz) for clarity rea-
sons. Following the work of Wegener et al., the resistance at 4 kHz
is presented and reﬂects a combination of intercellular (estab-
lishment of cell–cell junctions) and subcellular (cell–substrate
adhesion) alterations as well as cell motility (Wegener et al.,
2000). In contrast, the capacitance measurements at 64 kHz
translate linearly in cell coverage as most of the current is in-
tracellular at this frequency (Wegener et al., 2000).
2.5. Wound healing assay
Generally, impedance sensing with ECIS is achieved with a non-
invasive current of 1 mA generated by 1 V, AC signal passing
through a 1 MΩ resistor. However, a higher AC voltage (from
100 mV to 3 V) can be applied through a 1 kΩ resistor, thus gen-
erating an elevated current (0.1 mA to 3 mA), to wound the cell
layer. In this study, an elevated current pulse (3 mA, 40 kHz, 30 s)
generated by the ECIS microelectrodes and optimized by trial-and-
error experiments was used to wound the conﬂuent cell mono-
layer. The wounding pulse was mirrored by a drop in impedance to
that of the cell free electrode (Fig. 2(a)). The system then switched
back to its normal operation to monitor cell repair (Keese et al.,
2004). The same wounding parameters were used with all cell
lines.
In some cases, trypan blue was used to conﬁrm cell death.
15 min after wounding, the medium was aspirated and 200 μl of
diluted trypan blue was added to the well under investigation.
After 15 min, trypan blue was removed and the wounded cells
were optically observed. Only dead cells were stained blue as their
plasma membranes were terminally compromised.
2.6. Quantitative data analysis
2.6.1. Healing kinetics
ECIS data was exported to Matlab for further analysis. The
mean and standard errors were calculated for the different cell
lines. To better understand the healing kinetics, the healing graphs
were ﬁtted to a sigmoid curve in which the hill slope and inﬂec-
tion points were calculated using Eq. (1) shown in Supplementary
data, thus providing additional data on the differences between
case and control migration.
2.6.2. Average cell migration
The migration rate of the case and control cell lines after
electrical wounding was determined according to Eq. (2) in Sup-
plementary data.
2.6.3. Impedance based adhesion assay
Cells were seeded with a high density (typically
100,000 cells/cm2) and the changes in their impedances weremonitored for 1–2 days. The time it takes the cells to attach to the
electrode surface and start spreading till they form a conﬂuent
layer is an indicator of the cell adhesion properties (Wegener et al.,
2000; Heijink et al., 2010) (Fig. 1(d)). Attachment kinetics was
ﬁtted to a linear ﬁt and the slope of the case and control curves
were determined accordingly. A biochemical adhesion assay was
also performed to conﬁrm these results (See Supplementary data).
2.6.4. Cell–substrate adhesion parameter
The built-in ECIS model (Giaever and Keese, 1991) was used to
retrieve the cell adhesion parameter (α) to investigate the differ-
ences in cell–substrate adhesion between the cell lines under in-
vestigation. This model assumes cells as circular disks with radius
(r) hovering above the electrode at a distance (h) in a culture
medium with resistivity (ρ). The different current pathways (be-
tween, under and tough the cells) are then analyzed using differ-
ential equations to derive a transfer function deﬁning the complex
impedance and the model parameters. The ECIS adhesion para-
meter (α) is derived according to Eq. (1) and is a reﬂection of how
close the cells are to the electrode. A small cell–electrode distance
(h) indicates higher cell–electrode adhesion, i.e. more resistivity
against the current ﬂow underneath the cells.
r
h
cm
1
1/2α ρ= (Ω ) ( )
A schematic diagram of the ECIS model is shown in Supple-
mentary Fig. 1(c).
2.6.5. Moving variance
Matlab was used to analyze the increase in monitored im-
pedance ﬂuctuations accompanying cell differentiation by the
moving variance method (Schneider et al., 2011). First the signal
was detrended and normalized. Then the variance was calculated
over a total of 512 points (22.75 h) within a 150 point window and
a 1 point sliding step, and plotted against time.
2.6.6. Statisitcs
Matlab was also used to perform one-way Anova and Tukey–
Kramer multicomparison tests to determine whether the groups
under investigation were signiﬁcantly different from each other. A
probability value of Po0.01 was set as signiﬁcant.3. Results
3.1. An hiPSC-RPE model on ECIS microelectrode arrays
Induced pluripotent cells were successfully derived from a
patient with late-onset retinal macular degeneration (LORMD) and
one unaffected sibling. In each case the cells were then differ-
entiated towards RPE cells before being plated on ECIS micro-
electrode arrays (Fig. 1(a)). Final RPE maturation was completed on
the microelectrode arrays using a stepped 25-day protocol that
progressively moved towards a serum-free medium (Fig. 1(b)). The
hiPSC-RPE control and case cell lines were plated at conﬂuency
onto ECIS medusa arrays (Supplementary Fig. 1(a)) with a density
of 100,000 cells/well on day 0. Retinal differentiation medium
(RDM) was used as the culturing medium with the concentration
of fetal bovine serum being changed from 10% to 2% on day 2 and
then to 0% from day 6 onwards. Maturation of RPE took place on
top of the gold microelectrodes and was evidenced through the
changes in ECIS measurements.
Real-time quantitative monitoring of the spectroscopic com-
plex impedance, with a resistive and capacitive component, was
performed throughout the RPE maturation phase by acquiring
multi-frequency data points at a 160 s interval. The 25-day time-
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producible for both case (N¼9) and control wells (N¼11) thus
offering a criterion by which to reject faulty in vitro models. Fig. 1
(c) shows the changes in the resistance measured at 4 kHz that
characterised RPE maturation and was associated with initial cell
spreading, morphological changes and barrier formation with an
average standard error of 144.6Ω for the control cell line and
203.2Ω for the case. The resistance increased with cells attaching
and spreading onto the electrodes. First a steep increase in re-
sistance that peaked at 15 kΩ was observed on day 2 of culture
and this was followed by a slow decrease over 5.5 days to a plateau
with an average value of 8.5 kΩ. The formation of the conﬂuent
cell layer and the hiPSC-RPE differentiation stages were also ob-
served under a microscope. It was noticed that the drop in ECIS
measurements following the peak in resistance was mirrored by a
change in cell morphology from ﬁbroblastic-like cells towards
polygonal cobble-stone mature epithelial cells.
Finally, Fig. 1(c) shows that after RPE maturation, an electrical
wound healing assay was conducted directly on the chip as
schematically described in Supplementary data (Supplementary
Fig. 1(b)). An electrical pulse (3 mA, 40 kHz, 30 s) was used to in-
jure the cells on top of the electrode creating a reproducible 250
μm circular wound that mimicked cell loss and damage associated
with macular degeneration. A drop in resistance to the level of the
cell-free electrode (2600Ω) was monitored followed by a gradual
increase reﬂecting the migration of RPE cells to repopulate the
microelectrodes after wounding.
Before conducting the wound healing assay, the establishment
and maturation of the RPE layer on top of the microelectrodes
were conﬁrmed. Immunostaining (Fig. 1(d)) and RT-PCR analysis
(Fig. 1(e)) were used to identify RPE markers indicating RPE
maturation.
RT-PCR showed that both cell lines expressed the global epi-
thelial and RPE speciﬁc markers including the phagocytosis mar-
ker MERTK, the basal marker BEST1, the apical membrane asso-
ciated marker Ezrin, the pigmentation marker PEDF(pigment epi-
thelium derived factor), the visual cycle marker RPE65 as well as
C1QTNF5 and ACTIN. Moreover, qPCR was used to analyze the
relative fold change of expression of the selected mRNA of RPE
relative to iPS (Supplementary Fig. 2).
Taken together these data show that an hiPSCs-derived model
of the RPE layer can be developed directly on ECIS gold micro-
electrode arrays and that its robustness, reproducibility and suit-
ability can be quantitatively addressed by real-time impedance
sensing before initiating an integrated electrical wound healing
assay.
3.2. Electrical wound healing assays of the hiPSC-RPE layer
After 25 days, a mature RPE layer that entirely covered the
bottom of the culture well including the gold microelectrodes was
established. An RPE injury (analogous to focal RPE loss observed in
macular degeneration) was then created as a circular wound with
an elevated electrical pulse in the microelectrode area. Then the
wound healing process was monitored for both case and control
cell lines with ECIS.
Electrical pulse parameters have been optimized through trial
and error experiments. A 3 mA current pulse at 40 kHz applied for
30 s was found to cause cell death while preserving the micro-
electrode integrity. Fig. 2(a) shows the corresponding drop in R4kHz
that followed the electrical wound. R4kHz reached a value of
2600Ω corresponding to a cell-free electrode. This indicated cell
death. Light microscopy conﬁrmed that some cells detached from
the microelectrode while the few remaining were stained posi-
tively with trypan blue indicating irreversible electroporation and
death.Wound healing was then monitored until the RPE layer fully
recovered (5 days), and was characterised by two distinct phases
(Fig. 2(a)). First, the cells from the wound edges migrated under-
neath the layer of dead cells in a radial pattern to close the wound.
They repopulated the microelectrode with a characteristic steep
increase in resistance followed by a plateau that indicated the end
of cell migration. Then a maturation phase was observed where
the resistance slowly decreased to a second plateau in a similar
way to that described for early RPE maturation in Fig. 1(c). Light
microscopy indicated that once cell migration was complete,
elongated cells switched back to a cuboidal morphology indicating
RPE maturation at the end of this phase.
The mean and standard error of the migration phase for all case
and control cell lines is shown in Fig. 2(b). It shows that wounding
was a reproducible process, producing a deﬁned and concise
wound every time. The corresponding capacitance measurements
at 64 kHz are shown in Supplementary Fig. 3(a).When calculating
the migration rate as the time to repopulate a 250 μm electrode
(Fig. 2(d)), we found that the control cell line had a signiﬁcantly
(P¼0.0046) higher migration rate (10.6970.21 μm/h) than the
case cell line (8.670.46 μm/h).
In order to gain more insight into the healing kinetics, R4kHz
was ﬁtted to a sigmoid along the migration phase as exempliﬁed
for one case and one control cell line in Fig. 2(c). No signiﬁcant
difference (P¼0.057) was found between the hill slope as shown
in Fig. 2(e) of the control (0.5470.07) and that of the case cell
lines (0.4170.04). However, there was a signiﬁcant difference
between the case and control at the sigmoid inﬂection point. Fig. 2
(f) shows that the inﬂection point had a signiﬁcantly (P¼0.0009)
higher value for the case cell line (8.9470.29 h) than that of the
control cell line (7.0670.27 h).
These results suggested that the case lower migration rate (i.e.
the longer time taken by the cells to repopulate the electrodes) of
the case cell line might be attributed to a delay in initiating mi-
gration. Once the cells rearranged themselves radially and started
to move, they migrated with a speed similar to that of the control
cell line.
3.3. Observed similarities between healing and maturation processes
During the wound healing process, a transitional stage was
observed in which cells showed a change in morphology which
was similar to the changes accompanying the early RPE matura-
tion although on a much shorter time scale (Fig. 3(a)). Cells around
the wound edge went through a transition from cuboidal to
elongated cells before returning to their original polygonal mor-
phology after repopulating the electrodes (Fig. 3(b)). Increased
ﬂuctuations were also observed for these transitional phases. A
moving variance analysis was applied to the ECIS measurements
after wounding following the work of Schneider et al. (2011) (Fig. 3
(c)). The analysis clearly shows the transition from a high cellular
activity (high variance phase) to a more quiescent state (low var-
iance). No signiﬁcant differences were found between the case and
control cells with an average half-time transition of 11.5 h.
These data suggested that the case cell’s ability to go back to
the original RPE morphology after completing migration was not
affected by the LORMD mutation. Cell morphology and impedance
data strongly suggested that cells were able to close the wound
through integrin-mediated “mesenchymal” migration (Huttenlo-
cher and Horwitz, 2011).
3.4. Cell–substrate adhesion properties
One of the advantages of the tissue-on-a-chip approach is the
ability to exploit the quantitative impedance data collected
throughout RPE maturation and wound healing.
Fig. 3. Similarities between early RPE maturation and healing processes. (a) Differentiation and morphology changes: case and control cell lines changed their morphology
from a ﬁbroblastic-like to a cuboidal shape during the differentiation and maturation stage. This was accompanied by an increase in measurement ﬂuctuations. The
resistance decreased when the epithelial stage was reached which was attributed to the change in cell size and morphology. (b) Wounding and morphology changes:
unwounded cells changed morphology from cuboidal to elongated in order to migrate and repopulate the electrodes. The reverse process then occurred after closing the
wound. (c) Moving Variance showed a clear transition phase associated with a transition from an elongated to a cuboidal morphology.
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cell lines was at the ECIS attachment and spreading phase during
the ﬁrst 24 h after culture. R4kHz measurements showed that the
case cell line attached to the electrodes and spread to form a
conﬂuent layer more readily than the control cell line (Fig. 4(a)).
The corresponding capacitance measurements during the same
period are shown in Supplementary Fig. 3(b).
As the case and control cell lines were seeded at conﬂuency on
the microelectrode arrays, the ﬁrst 24 h of measurements wereconsidered to constitute an impedance-based adhesion assay re-
vealing data on the cell–substrate adhesion. Generally in these
types of assays, the microelectrodes are entirely covered with a
tight layer of cells that upon attachment to the electrode surface
causes a signiﬁcant increase in the measured resistance. The dif-
ference in the measurements between different cell lines can
therefore be attributed to cell attachment and adhesion to the
substrate (Wegener et al., 2000).
For further analysis, the slope of each of the attachment curves
Fig. 4. Case vs. control cell–substrate adhesion. (a) The hiPSC-RPE ECIS adhesion assay: comparing the resistances of the case and control cell lines during the ﬁrst 24 h of
culture, showed how the case cell line attached more quickly to the electrodes and were able to reach a plateau faster than the control cell line. (b) Attachment slope: the
slopes of the attachment curves for both case and control cell lines were calculated through a linear ﬁt. The slope was signiﬁcantly higher for the case cell line (Po0.01)
which was consistent with the case cells arriving at a plateau before the control cells. (c) Cell–substrate adhesion parameter (α): ECIS parameter (alpha) of the case cell line
was signiﬁcantly higher than that of the control cell line (P¼0.002), indicating that the case cell line obtained a higher cell–substrate adhesion. (d) Adhesion biochemical
assay: the case cell line showed stronger adhesion to various ECM proteins than the control cell line.
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niﬁcantly different (Po0.01) with a value of 5.4570.64Ω/h for
the control and 9.4370.76Ω/h for the case cell line (Fig. 4(b)).
After this attachment phase however, the case and control cell
lines followed similar kinetics throughout the differentiation and
maturation phases (see Supplementary Fig 4).
To further investigate the potential role of cell adhesion, the
ECIS model was used to deﬁne the cell–substrate adhesion para-
meter (α) (Fig. 4(c)). Again the case cell line showed signiﬁcantly
(Po0.01) higher adhesion (7.870.28Ω1/2 cm) than the control
cell line (6.570.15Ω1/2 cm).
These ﬁndings were conﬁrmed by a biochemical adhesion as-
say (Fig. 4(d)) that showed a clear difference between the adhe-
sion properties of the case and control cell lines. The case line
showed a signiﬁcantly higher adhesion to ECM proteins (including
collagen IV and tenascin) than the control cell line. Note that for
the case and control cells cultured on ECIS arrays, the microelec-
trodes were coated with a mixture of proteins present in serum
prior to culture.
Finally, to explore further the link between cell adhesion and
cell migration, electrical wounding of an additional RPE cell line
was conducted (Fig. 5(a)). The immortalized cell line htert-RPE1
were chosen for this study as they are regularly used for in vitro
RPE migration assays even with their reported limitations in re-
ﬂecting in vivo behavior (Alge et al., 2006; Klimanskaya et al.,
2004). After htert-RPE1 reached conﬂuency, an ECIS woundhealing assay was conducted and its healing rate and adhesion
properties were compared to that of the hiPSC-RPE (Fig. 5(b) and
(c)). The wounding parameters for htert-RPE1 were the same as
that for the hiPSC-RPE case and control cell lines (3 mA, 40 kHz,
30 s). In contrast to the hiPSC-RPE, the wounded cells completely
detached leaving a clear electrode, which already suggested that
the cells adhered less to the electrodes. Comparing the cell–sub-
strate ECIS parameters of the different cell lines showed that htert-
RPE1 were the least adherent to the electrode's surface followed
by the control hiPSC-RPE and then by the case cell line having the
highest α. This was in turn reﬂected in the migration rates
with the immortalized htert-RPE1 having the highest migration
rate of 14.7970.39 μm/h followed by the control cell line
(10.6970.21 μm/h) and then by the case line (8.670.46 μm/h)
with the slowest migration rate of the three cell lines. These data
strongly suggest that the difference observed in cell migration rate
between the case and the control cell line may be attributed to a
difference in cell adhesion properties.4. Discussion
In this study, a tissue-on-a chip approach was developed to
investigate RPE layer damage and repair in order to mimic retinal
macular degeneration. Differences in wound healing between a
case and control RPE cell lines associated with an inherited
Fig.5. Effect of cell–substrate adhesion on the migration of immortalized and hiPSC-derived RPE (a) Wounding htert-RPE1: wounding parameters used for the migration
assay were 3 mA, 40 kHz, 30 s. Wounded cells completely detached from the electrode surface upon wounding leaving clear electrodes. Wound healing was achieved as cells
migrated to repopulate the electrode. (b) Cell–substrate adhesion: htert-RPE1 had the lowest adhesion parameter (α), followed by the control cell line and the case line with
the highest α. (c) Migration rates: htert-RPE1 had the highest migration rate. It was followed by the control hiPSC-RPE cell line and then by the case cell line.
W. Gamal et al. / Biosensors and Bioelectronics 71 (2015) 445–455 453macular degeneration were reproducibly and quantitatively iden-
tiﬁed. The obtained results demonstrated that the healing rate was
reduced in the case cell line. The differences in healing resulted
from a reduced migration rate in the case RPE line when compared
to the control RPE line. In addition, the cell lines were found tohave different cell–substrate adhesion properties, which may be
the reason behind the different cell migration rates. Moreover, the
cells undergoing migration adopted a radial pattern of wound
healing around the site of damage suggesting a single cell “me-
senchymal” migration as opposed to collective “Ameboid”
W. Gamal et al. / Biosensors and Bioelectronics 71 (2015) 445–455454migration. (Huttenlocher and Horwitz, 2011). “Mesenchymal”
migration is integrin dependent and therefore directly linked to
cell adhesion properties.
Increased ﬂuctuations in impedance measurements after
wounding as well as during maturation were associated with a
change in cell morphology from cuboidal to elongated shape. In-
creased ﬂuctuations monitored by ECIS were reported previously
by Schneider et al. (Schneider et al., 2011) and were attributed to
the rufﬂing of cell membranes during EMT (epithelial-to-me-
senchymal-transition) process. Taken together, these results point
towards an EMT/MET transition post wounding which is known to
play a role in development as well as migration in other cell lines
(Lane and Jiang, 2012; Lane and Jiang, 2013) and in RPE (Chen
et al., 2014). Both the control and case lines went through a
morphological change towards a mesenchymal like state during
migration before going back to a cuboidal morphology after re-
populating the microelectrodes.
Although the central role of cell adhesion in cell migration is
established, the relation between migration rate and adhesion
level is more subtle. Generally a cell line will have an optimum cell
migration rate at intermediate levels of adhesion to allow both an
efﬁcient cell–substrate attachment and release (Gupton and Wa-
terman-Storer, 2006). In the presented study, the lower migration
rate of the case cell line was found to be associated with a stronger
cell–substrate adhesion than that of the control cell line. In this
study adhesion and migration parameters were measured sepa-
rately and thus represent independent, quantitative parameters
that will help to achieve a better understanding of the complex
relationship between adhesion and migration, and could be used
to identify potential therapeutic agents that promote cell migra-
tion by modulating cell adhesion (lower or higher).
The case cell line (late onset retinal macular degeneration) re-
sults from a mutation in the gene encoding the protein C1QTNF5
(Hayward et al., 2003). C1QTNF5 protein is composed of a C1Q-like
globular head, a collagen-like domain and a signal peptide (Tu and
Palczewski, 2012). The normal function of C1QTNF5 is currently
unknown, however in the eye; it is thought to play a part in in-
teractions between the RPE and the underlying basement mem-
brane since the protein is secreted by the RPE and then attaches to
the baso-lateral RPE plasma membrane (Mandal et al., 2006).
Previous studies have indicated that mutant C1QTNF5 may affect
cellular adhesion. Studies performed by Shu et al. (2006) found
that HEK-EBNA cells stably expressing C1QTNF5 had reduced ad-
hesion to laminin coated plates when compared with cells trans-
fected with wild type protein. However, no differences were found
when comparing ﬁbronectin coated plates. These differences
might have resulted from a number of causes including inherent
adhesion differences in the cell lines (Kuschel et al., 2006). ECIS
Medusa microarrays in this study were coated only with FCS and
not with laminin, which may result in a different cell–substrate
adhesion proﬁle. Further studies will need to be performed using
other substrates for comparison.
There have been previous studies on the effect of different
agents on the adhesion and migration of RPE (Chan et al., 2010;
Tsapara et al., 2010). Chan et al. have investigated the role of an-
tioxidants on RPE adhesion and migration using ECIS wound
healing assays. They studied the inhibitory effect of (-)-Epigallo-
catechin gallate (EGCG) (Chan et al., 2010), resveratrol (Chan et al.,
2013) and lycopene (Chan et al., 2009) on platelet-derived growth
factor (PDGF-BB) induced ARPE19 cell migration and adhesion to
ﬁbronectin. They reported that while all the three antioxidants
have inhibited PDGF-BB induced RPE migration, only (-)-EGCG had
an effect on adhesion to ﬁbronection. Reservatrol and lycopene
inhibited migration signaling pathways with no effect on adhe-
sion. In vivo, optical coherence tomography studies in AMD sug-
gested that aberrant adhesion/migration of intraretinal RPE mightunderlie progression to more advanced disease (Ho et al., 2011).
Finally, it is worth noting that RPE migration can be stimulated
by an externally applied electrical ﬁeld, and electrotaxis has been
pointed out as a potential therapeutic strategy (Gamboa et al.,
2010). However, RPE stimulated migration was observed at vol-
tages orders of magnitude (50–300 mV) above the voltage used in
this study (microvolts). The disease model-on-a-chip approach
that have been developed in this study is well suited to investigate
further the effect of different agents and drugs on migration and
adhesion of both case and control cell lines, and can be adapted to
the investigation of other inherited diseases.
Tissue-on-a-chip platforms are an emerging technology in drug
discovery, tissue engineering and regenerative medicine (Borooah
et al., 2013; Inoue and Yamanaka, 2011). So far, only a few studies
restricted to the ﬁeld of cardio-electrophysiology (Inoue and Ya-
manaka, 2011; Navarrete et al., 2013) have explored the combi-
nation of microelectrodes arrays and iPSC technologies. Human
iPSCs-based models-on-a-chip show a new pathway for disease
modeling and are beginning to establish a new paradigm for drug
development and personalized medicine (Inoue and Yamanaka,
2011; Navarrete et al., 2013).5. Conclusion
This study has demonstrated a reproducible and robust tissue-
on-a-chip approach to quantitatively study a patient-speciﬁc ret-
inal macular degeneration disease model. An hiPSC-RPE layer was
directly established on ECIS microelectrodes where the platform
enabled the label-free, real-time monitoring of hiPSC-RPE ma-
turation in addition to injury and repair through the application of
an integrated electrical wounding assay. This method mimicked
RPE cell loss accompanying macular degeneration and was used to
detect variations in migration rate between a cell line derived from
a patient with late-onset retinal macular degeneration versus a
control cell line derived from an unaffected siblings. This study
points towards the role of cell adhesion in repair and will facilitate
further studies to test the efﬁcacy of potential therapeutic agents
that modulate cell adhesion.
The tissue-on-a-chip AMD model is a powerful platform for
translational studies. Combining hiPSCs technology with im-
pedance sensing, it is amenable to a high throughput thus offering
the opportunity to study patient-speciﬁc inherited macular de-
generation in order to help achieve a better understanding of the
disease mechanisms and identify potential therapies.Acknowledgements
We thank Karen Burr and David Story for assistance with
hiPSCs culture, Nina Rzechorzek and Elaine Cleary for technical
assistance, Dr. Colin Campbell for providing immortalized RPE cell
lines. We would also like to particularly express our gratitude to
Dr. Ludovic Vallier and Dr. David Gamm for their guidance and
advices. We would like to acknowledge ﬁnancial support from the
College of Science and Engineering, The University of Edinburgh,
the Eye Research Fund Edinburgh and Lothian Health Foundation.
Shyamanga Borooah acknowledges support from the Royal College
of Surgeons of Edinburgh, Eyecare charity, Wellcome Trust STMTI
scheme (grant number R42141). Pierre Bagnaninchi and Stewart
Smith acknowledge support from RCUK fellowships.
Appendix A. Supplementary material
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.bios.2015.04.079.
W. Gamal et al. / Biosensors and Bioelectronics 71 (2015) 445–455 455References
Alge, C.S., Hauck, S.M., Priglinger, S.G., Kampik, A.M.U., 2006. Differential protein
proﬁling of primary versus immortalized human RPE cells identiﬁes expression
patterns associated with cytoskeletal remodelling and cell survival. J. Proteome
Res. 5 (4), 862–878.
Bagnaninchi, P.O., Drummond, N., 2011. Real-time label-free monitoring of adipose-
derived stem cell differentiation with electric cell-substrate impedance sensing.
Proc. Natl. Acad. Sci. 108 (16), 6462–6467.
Bilican, B., Serio, A., Barmada, S.J., Nishimura, A.L., Carrasco, M., Phatnani, H.P.,
Puddifoot, C.A., Story, D., Fletcher, J., Park, I.H., Friedman, B.A., Daley, G.Q.,
Wyllie, D.J., Hardingham, G.E., Wilmut, I., Finkbeiner, S., Maniatis, T., Shaw, C.E.,
Chandran, S., 2012. Mutant induced pluripotent stem cell lines recapitulate
aspects of TDP-43 proteinopathies and reveal cell-speciﬁc vulnerability. Proc.
Natl. Acad. Sci. 109 (15), 5803–5808.
Borooah, S., Collins, C., Wright, A., Dhillon, B., 2009. Late-onset retinal macular
degeneration: clinical insights into an inherited retinal degeneration. Postgrad.
Med. J. 85, 495–500.
Borooah, S., Phillips, M.J., Bilican, B., Wright, A.F., Wilmut, I., Chandran, S., Gamm, D.,
Dhillon, B., 2013. Using human induced pluripotent stem cells to treat retinal
disease. Progr. Ret. Eye Res. 37, 163–181.
Cai, H., Del Priore, L.V., 2006. Bruch membrane aging alters the gene expression
proﬁle of human retinal pigment epithelium. Curr. Eye Res. 31 (2), 181–189.
Chan, C.M., Chang, H.H., Wang, V.C., Huang, C.L., Hung, C.F., 2013. Inhibitory effects
of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via
PDGFRb,PI3K/Akt and MAPK pathways. PLoS One 8 (2), e56819.
Chan, C.M., Fang, J.Y., Lin, H.H., Yang, C.Y., Hung, C.F., 2009. Lycopene inhibits PDGF-
BB-induced retinal pigment epithelial cell migration by suppression of PI3K/Akt
and MAPK pathways. Biochem. Biophys. Res. Commun. 388, 172–176.
Chan, C.M., Huang, J.H., Chiang, H.S., Wu, W.B., Lin, H.H., Hong, J.Y., Hung, C.F., 2010.
Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion. Mol.
Vis. 16, 586–595.
Chen, X., Xiao, W., Wang, W., Luo, L., Ye, S., Liu, Y., 2014. The complex interplay
between ERK1/2, TGFβ/Smad, and Jagged/Notch signaling pathways in the
regulation of epithelial-mesenchymal transition in retinal pigment epithelium
cells. PLoS One 9 (5), e96365.
David Schneider, D., Tarantola, M., Janshoff, A., 2011. Dynamics of TGF-β induced
epithelial-to-mesenchymal transition monitored by Electric Cell–Substrate
Impedance Sensing. Biochim. Biophys. Acta 1813 (12), 2099–2107.
Doran, M.R., Mills, R.J., Parker, A.J., Landman, K.A., Cooper-White, J.J., 2009. A cell
migration device that maintains a deﬁned surface with no cellular damage
during wound edge generation. Lab Chip 9, 2364–2369.
Fronzaa, M., Heinzmann, B., Hamburger, M., Laufer, S., Merfort, I., 2009. Determi-
nation of the wound healing effect of Calendula extracts using the scratch assay
with 3T3 ﬁbroblasts. J. Ethnopharmacol. 126, 463–467.
Gamboa, O.L., Pu, J., Townend, J., Forrester, J.V., Zhao, M., McCaig, C., Lois, N., 2010.
Electrical estimulation of retinal pigment epithelial cells. Exp. Eye Res. 91,
195–204.
Giaever, I., Keese, C.R., 1984. Monitoring ﬁbroblast behaviour in tissue culture with
an applied electric ﬁeld. Proc. Natl. Acad. Sci. USA 81 (12), 3761–3764.
Giaever, I., Keese, C.R., 1991. Micromotion of mammalian cells measured elec-
trically. Proc. Natl. Acad. Sci. 88, 7896–7900.
Gupton, S.L., Waterman-Storer, C.M., 2006. Spatiotemporal feedback between ac-
tomyosin and focal-adhesion systems optimizes rapid cell migration. Cell 125,
1361–1374.
Han, J., Liu, G., Proﬁrovic, J., Niu, J., Voyno-Yasenetskaya, T., 2009. Zyxin is involved
in thrombin signaling via interaction with PAR-1 receptor. FASEB 23,
4193–4206.
Hayward, C., Shu, X., Cideciyan, A., Lennon, A., Barran, P., Zareparsi, S., Sawyer, L.,
Hendry, G., Dhillon, B., Milam, A., Luthert, P., Swaroop, A., Hastie, N., Jacobson,
S., Wright, A., 2003. Mutation in a short-chain collagen gene, CTRP5, results in
extracellular deposit formation in late-onset retinal degeneration: a genetic
model for age-related macular degeneration. Hum. Mol. Genet. 12 (20),
2657–2667.
Heijink, I.H., Brandenburg, S.M., Noordhoek, J.A., Postma, D.S., Slebos, D.J., van
Oosterhout, A.J.M., 2010. Characterisation of cell adhesion in airway epithelial
cell types using electric cell–substrate impedance sensing. Eur. Respir. J. 35,
894–903.
Ho, J., Witkin, A.J., Liu, J., Chen, Y., Fujimoto, J.G., Schuman, J.S., Duker, J.S., 2011.
Documentation of intraretinal pigment epithelium migration via high-speed
ultrahigh-resolution optical coherence tomography. Ophthalmology 118 (4),
687–693.
Huttenlocher, A., Horwitz, A.R., 2011. Integrins in cell migration. Cold Spring Harb.
Perspect. Biol. 3, a005074.
Inoue, H., Yamanaka, S., 2011. The use of induced pluripotent stem cells in drug
development. Clin. Pharmacol. Ther. 89 (5), 655–661.
Johnson, P.T., Brown, M.N., Pulliam, B.C., Anderson, D.H., Johnson, L.V., 2005. Sy-
naptic pathology, altered gene expression, and degeneration in photoreceptors
impacted by drusen. Invest. Ophthalmol. Vis. Sci. 46, 4788–4795.
Keese, C.R., Bhawe, K., Wegener, J., Giaever, I., 2002. Real-time impedance assay to
follow the invasive activities of metastatic cells in culture. BioTechniques 33,842–850.
Keese, C.R., Wegener, J., Walker, S.R., Giaever, I., 2004. Electrical wound-healing
assay for cells in vitro. Proc. Natl. Acad. Sci. 101 (6), 1554–1559.
Klimanskaya, I., Hipp, J., Rezai, K.A., West, M., Atala, A.,R.,L., 2004. Derivation and
comparative assessment of retinal pigment epithelium from human embryonic
stem cells using transcriptomics. Clon. Stem Cells 6 (3), 217–245.
Kuschel, C., Steuer, H., Maurer, A., Kanzok, B., Stoop, R., Angres, B., 2006. Cell ad-
hesion proﬁling using extracellular matrix protein microarrays. Biotechniques
40 (4), 523–531.
Lane, J., Jiang, W.G., 2012. Epithelial-mesenchymal transition and the use of ECIS. In:
Jiang, W.G. (Ed.), Electric Cell-Substrate Impedance Sensing and Cancer Me-
tastasis. Springer, pp. 71–84.
Lane, J., Jiang, W.G., 2013. Metastasis suppressor 1 (MTSS1) and epithelial to me-
senchymal transition (EMT) in cancer progression. Eur. J. Cancer 49, S132-S132.
Lee, J., Wang, Y., Ren, F., Lele, T.P., 2010. Stamp wound assay for studying coupled
cell migration and cell debris clearance. Langmuir 26 (22), 16672–16676.
Legrand, C., Gilles, C., Zahm, J., Polette, M., Buisson, A., Kaplan, H., Birembaut, P.,
Tournier, J., 1999. Airway epithelial cell migration dynamics: mmp-9 role in
cell-extracellular matrix remodeling. J. Cell Biol. 146 (2), 517–529.
Li, M., Firth, J.D., Putnins, E.E., 2009. An in vitro analysis of mechanical wounding-
induced ligand-independent KGFR activation. J. Dermatol. Sci. 53, 182–191.
Lo, C.M., Keese, C.R., Giaever, I., 1995. Impedance analysis of MDCK cells measured
by electric cell–substrate impedance sensing. Biophys. J. 69, 2800–2807.
Lovelady, D.C., Friedman, J., Patel, S., Rabson, D.A., Lo, C., 2009. Detecting effects of
low levels of cytochalasin B in 3T3 ﬁbroblast cultures by analysis of electrical
noise obtained from cellular micromotion. Biosens. Bioelectron. 24, 2250–2254.
Mandal, M., Vasireddy, V., Reddy, G., Wang, X., Moroi, S., Pattnaik, B., Hughes, B.,
Heckenlively, J., Hitchcock, P., Jablonski, M., Ayyagari, R., 2006. CTRP5 is a
membrane-associated and secretory protein in the RPE and ciliary body and the
S163R mutation of CTRP5 impairs its secretion. Invest. Ophthalmol. Vis. Sci. 47
(12), 5505–5513.
Meyer, J.S., Shearer, R.L., Capowski, E.E., Wright, L.S., Wallace, K.A., McMillan, E.L.,
Zhang, S.C., Gamm, D.M., 2009. Modeling early retinal development with hu-
man embryonic and induced pluripotent stem cells. Proc. Natl. Acad. Sci. 106,
16698–16703.
Navarrete, E.G., Liang, P., Lan, F., Sanchez-Freire, V., Simmons, C., Gong, T., Sharma,
A., Burridge, P.W., Patlolla, B., Lee, A.S., Wu, H., Beygui, R.E., Wu, S.M., Robbins, R.
C., Bers, D.M., Wu, J.C., 2013. Screening drug-induced arrhythmia using human
induced pluripotent stem cell-derived cardiomyocytes and low-impedance
microelectrode arrays. Circulation 128, S3:S13.
Opp, D., Wafula, B., Lim, J., Huang, E., Lo, J., Lo, C., 2009. Use of electric cell-substrate
impedance sensing to assess in vitro cytotoxicity. Biosens. Bioelectron. 24,
2625–2629.
Panda-Jonas, S., Jonas, J.B.,M.,J.-Z., 1996. Retinal pigment epithelial cell count, dis-
tribution, and correlations in normal human eyes. Am. J. Ophthalmol. 121 (2),
181–189.
Poujade, M., Grasland-Mongrain, E., Hertzog, A., Jouanneau, J., Chavrier, P., Ladoux,
B., Buguin, A., Silberzan, P., 2007. Collective migration of an epithelial mono-
layer in response to a model wound. Proc. Natl. Acad. Sci. 104 (41),
15988–15993.
Shu, X., Tulloch, B., Lennon, A., Vlachantoni, D., Zhou, X., Hayward, C.A.F.W., 2006.
Disease mechanisms in late-onset retinal macular degeneration associated with
mutation in C1QTNF5. Hum. Mol. Genet. 15 (10), 1680–1689.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., Yamanaka,
S., 2007. Induction of pluripotent stem cells from adult human ﬁbroblasts by
deﬁned factors. Cell 131, 861–872.
Thurman, J.M., Renner, B., Kunchihapautham, K., Ferreira, V.P., Pangbum, M.K.,
Ablonczy, Z., Tomlinson, S., Holers, V.M., Rohrer, B., 2009. Oxidative stress
renders retinal pigment epithelial cells susceptible to complement mediated
injury. J. Biol. Chem. 284 (25), 16939–16947.
Tsapara, A., Luthert, P., Greenwood, J., Hill, C.S., Matter, K., Balda, M.S., 2010. The
RhoA activator GEF-H1/Lfc is a transforming growth factor-beta target gene and
effector that regulates alpha-smooth muscle actin expression and cell migra-
tion. Mol. Biol. Cell 21, 860–870.
Tu, X., Palczewski, K., 2012. Crystal structure of the globular domain of C1QTNF5:
implications for late-onset retinal macular degeneration. J. Struct. Biol. 180 (3),
439–446.
Varani, J., Orr, W., Ward, P.A., 1978. A comparison of the migration patterns of
normal and malignant cells in two assay systems. Am. J. Pathol. 90, 159–172.
Wegener, J., Keese, C.R., Giaever, I., 2000. Electric cell–substrate impedance sensing
(ECIS) as a noninvasive means to monitor the kinetics of cell spreading to ar-
tiﬁcial surfaces. Exp. Cell Res. 259, 158–166.
Yusa, K., Rashid, S.T., Strick-Marchand, H., Varela, I., Liu, P.Q., Paschon, D.E., Miranda,
E., Ordóñez, A., Hannan, N.R., Rouhani, F.J., Darche, S., Alexander, G., Marciniak,
S.J., Fusaki, N., Hasegawa, M., Holmes, M.C., Di Santo, J.P., Lomas, D.A., Bradley,
A., L., V., 2011. Targeted gene correction of α1-antitrypsin deﬁciency in induced
pluripotent stem cells. Nature 478 (7369), 391–394.
Zordan, M.D., Mill, C.P., Riese, D.J., Leary, J.F., 2011. A high throughput, interactive
imaging, bright-ﬁeld wound healing assay. Cytom. Part A 79A, 227–232.
